Risk factors for COVID-19 hospitalization after COVID-19 vaccination: a population-based cohort study in Canada

被引:5
|
作者
Garcia, Hector A. Velasquez [1 ,2 ]
Adu, Prince A. [1 ,2 ]
Harrigan, Sean [1 ]
Wilton, James [1 ]
Rasali, Drona [1 ]
Binka, Mawuena [2 ]
Sbihi, Hind [1 ]
Smolina, Kate [1 ,2 ]
Janjua, Naveed Z. [1 ,2 ,3 ]
机构
[1] British Columbia Ctr Dis Control, Data & Analyt Serv, Vancouver, BC, Canada
[2] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC, Canada
[3] St Pauls Hosp, Ctr Hlth Evaluat & Outcome Sci, Vancouver, BC, Canada
基金
加拿大健康研究院;
关键词
COVID-19; Vaccination; Hospitalization; Risk factors; Canada;
D O I
10.1016/j.ijid.2022.12.001
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives: With the uptake of COVID-19 vaccines, there is a need for population-based studies to assess risk factors for COVID-19-related hospitalization after vaccination and how they differ from unvaccinated individuals.Methods: We used data from the British Columbia COVID-19 Cohort, a population-based cohort that includes all individuals (aged >= 18 years) who tested positive for SARS-CoV-2 by real-time reverse transcription-polymerase chain reaction from January 1, 2021 (after the start of vaccination program) to December 31, 2021. We used multivariable logistic regression models to assess COVID-19-related hospi-talization risk by vaccination status and age group among confirmed COVID-19 cases.Results: Of the 162,509 COVID-19 cases included in the analysis, 8,546 (5.3%) required hospitalization. Among vaccinated individuals, an increased odds of hospitalization with increasing age was observed for older age groups, namely those aged 50-59 years (odds ratio [OR] = 2.95, 95% confidence inter-val [CI]: 2.01-4.33), 60-69 years (OR = 4.82, 95% CI: 3.29, 7.07), 70-79 years (OR = 11.92, 95% CI: 8.02, 17.71), and >= 80 years (OR = 24.25, 95% CI: 16.02, 36.71). However, among unvaccinated individuals, there was a graded increase in odds of hospitalization with increasing age, starting at age group 30-39 years (OR = 2.14, 95% CI: 1.90, 2.41) to >= 80 years (OR = 41.95, 95% CI: 35.43, 49.67). Also, comparing all the age groups to the youngest, the observed magnitude of association was much higher among unvaccinated individuals than vaccinated ones.Conclusion: Alongside a number of comorbidities, our findings showed a strong association between age and COVID-19-related hospitalization, regardless of vaccination status. However, age-related hospitaliza-tion risk was reduced two-fold by vaccination, highlighting the need for vaccination in reducing the risk of severe disease and subsequent COVID-19-related hospitalization across all population groups.(c) 2022 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )
引用
收藏
页码:116 / 123
页数:8
相关论文
共 50 条
  • [1] Colchicine and risk of hospitalization due to COVID-19: A population-based study
    Saenz-Aldea, Maria
    Salgado-Barreira, Angel
    Trunk, Margarita Taracido
    Pineiro-Lamas, Maria
    Herdeiro, Maria T. T.
    Portela-Romero, Manuel
    Saez, Marc
    Figueiras, Adolfo
    JOURNAL OF MEDICAL VIROLOGY, 2023, 95 (02)
  • [2] Risk of COVID-19 in pediatric population and the effects of COVID-19 vaccination: A retrospective cohort study
    Corona, Kassandra
    Saripada, Janisah Amirah I.
    Wermine, Kendall
    Seavey, Sydney
    Figueira, Bibiana Toro
    LaHaye, Joshua J.
    Yoshiyasu, Yuki
    Daram, Shiva
    McKinnon, Brian
    AURIS NASUS LARYNX, 2024, 51 (03) : 481 - 487
  • [3] Hypertension and Related Comorbidities as Potential Risk Factors for COVID-19 Hospitalization and Severity: A Prospective Population-Based Cohort Study
    Fresan, Ujue
    Guevara, Marcela
    Trobajo-Sanmartin, Camino
    Burgui, Cristina
    Ezpeleta, Carmen
    Castilla, Jesus
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (06) : 1 - 12
  • [4] COVID-19 hospitalization, mortality and premature mortality by a history of immigration in Ontario, Canada: a population-based cohort study
    Wanigaratne, Susitha
    Shah, Baiju
    Stukel, ThereseA.
    Lu, Hong
    Den Otter-Moore, Sophia
    Shetty, Janavi
    Saunders, Natasha
    Gandhi, Sima
    Guttmann, Astrid
    LANCET REGIONAL HEALTH-AMERICAS, 2024, 34
  • [5] A Population-Based Analysis of the Risk of Glomerular Disease Relapse after COVID-19 Vaccination
    Canney, Mark
    Atiquzzaman, Mohammad
    Cunningham, Amanda M.
    Zheng, Yuyan
    Er, Lee
    Hawken, Steven
    Zhao, Yinshan
    Barbour, Sean J.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (12): : 2247 - 2257
  • [6] Cohort profile: an observational population-based cohort study on COVID-19 vaccine effectiveness in the Netherlands - the VAccine Study COVID-19 (VASCO)
    Huiberts, Anne J.
    Hoeve, Christina E.
    Kooijman, Marjolein N.
    de Melker, Hester E.
    Hahne, Susan J. M.
    Grobbee, Diederick E.
    van Binnendijk, Rob
    den Hartog, Gerco
    van de Wijgert, Janneke H. H. M.
    van den Hof, Susan
    Knol, Mirjam J.
    BMJ OPEN, 2024, 14 (10):
  • [7] Risk of newly diagnosed interstitial lung disease after COVID-19 and impact of vaccination: a nationwide population-based cohort study
    Kim, Bo-Guen
    Lee, Hyun
    Jeong, Cho Yun
    Yeom, Sang Woo
    Park, Dong Won
    Park, Tai Sun
    Moon, Ji-Yong
    Kim, Tae-Hyung
    Sohn, Jang Won
    Yoon, Ho Joo
    Kim, Jong Seung
    Kim, Sang-Heon
    FRONTIERS IN PUBLIC HEALTH, 2024, 11
  • [8] Mental Health and Substance Use Associated with Hospitalization among People with COVID-19: A Population-Based Cohort Study
    Garcia, Hector Alexander Velasquez
    Wilton, James
    Smolina, Kate
    Chong, Mei
    Rasali, Drona
    Otterstatter, Michael
    Rose, Caren
    Prystajecky, Natalie
    David, Samara
    Galanis, Eleni
    McKee, Geoffrey
    Krajden, Mel
    Janjua, Naveed Zafar
    VIRUSES-BASEL, 2021, 13 (11):
  • [9] Risk of COVID-19 hospitalization in people living with HIV and HIV-negative individuals and the role of COVID-19 vaccination: A retrospective cohort study
    Puyat, Joseph H.
    Fowokan, Adeleke
    Wilton, James
    Janjua, Naveed Z.
    Wong, Jason
    Grennan, Troy
    Chambers, Catharine
    Kroch, Abigail
    Costiniuk, Cecilia T.
    Cooper, Curtis L.
    Lauscher, Darren
    Strong, Monte
    Burchell, Ann N.
    Anis, Aslam H.
    Samji, Hasina
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2023, 135 : 49 - 56
  • [10] The risk of COVID-19 in patients with bullous pemphigoid and pemphigus: A population-based cohort study
    Kridin, Khalaf
    Schonmann, Yochai
    Weinstein, Orly
    Schmidt, Enno
    Ludwig, Ralf J.
    Cohen, Arnon D.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (01) : 79 - 87